首页> 外文期刊>International surgery >Evaluation of the prognostic factors after thymoma resection.
【24h】

Evaluation of the prognostic factors after thymoma resection.

机译:胸腺瘤切除术后预后因素的评估。

获取原文
获取原文并翻译 | 示例
       

摘要

We discuss the prognostic factors of thymoma clinicopathologically. Regarding the survival rate by the clinical stage classification of Masaoka, significant correlation was made between stage I and stage III (P < 0.05) and stage I and stage IVa (P < 0.03). The tumor resectability was classified into complete and incomplete resection, and a significant difference was shown by the survival rate of the complete resection at P < 0.0001. Regarding the survival rate by the invasive organ of the tumor, significant correlation was made between no invasion and the great vessel invasion (P < 0.0004) and between invasion except for the great vessel and great vessel invasion (P < 0.004). As for the histological type, the tendency in which the epithelial cell type predominancy increased with the progress of the clinical stage was shown. A significant correlation was not shown in the evaluation by adjuvant therapy. However, recently we have done chemotherapy and/or radiotherapy periodically for invasive thymoma.
机译:我们在临床病理上讨论胸腺瘤的预后因素。根据Masaoka临床分期的存活率,I期和III期(P <0.05)与I期和IVa期(P <0.03)之间存在显着相关性。将肿瘤的可切除性分为完全切除和不完全切除,并且在P <0.0001时,完全切除的存活率显示出显着差异。关于肿瘤的浸润器官的存活率,在无浸润和大血管浸润之间(P <0.0004)以及在除了大血管和大血管浸润以外的浸润之间(P <0.004)之间存在显着相关性。至于组织学类型,显示出随着临床阶段的进展上皮细胞类型占优势的趋势。辅助治疗的评估未显示显着相关性。但是,最近我们已经针对浸润性胸腺瘤定期进行化学疗法和/或放疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号